Kirn David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$8.27M

Insider Activity of Kirn David

According to the SEC Form 4 filings, Kirn David, being in a position of

  1. See Remarks at 4D Molecular Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 400000 shares for $5.01M,
    over all time since 2022-12-15, has bought 0 shares, and sold 766700 shares for $13.28M.

Biography of Kirn David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,010,0529100

Comparison of Insiders on Amount of Buys and Sells

2026-10-05Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
58,333
0.083%
$12.92$753,937-4.33%
2026-09-14Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
58,333
0.0839%
$13.90$811,004-6.07%
2026-08-19Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
69,076
0.1242%
$15.75$1.09M-17.9%
2026-08-04Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
26,842
0.0512%
$10.23$274,596+32.16%
2026-08-03Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
12,415
0.0182%
$10.05$124,722+33.7%
2026-07-10Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
15,725
0.0294%
$12.03$189,233+3.82%
2026-07-09Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
42,608
0.0814%
$12.87$548,177-1.16%
2026-06-22Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
114,746
0.2205%
$10.47$1.2M+22.36%
2026-06-01Sale4D Molecular Therapeutics, Inc.
FDMT
See Remarks
1,922
0.0038%
$10.02$19,258+27.03%
2024-07-10Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
12,923
0.0268%
$22.49$290,598-74.92%
2024-06-24Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
12,930
0.0248%
$23.10$298,711-72.75%
2024-02-08Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
92,001
0.3275%
$27.13$2.5M-41.34%
2024-01-23Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
5,696
0.0133%
$18.41$104,851-6.55%
2024-01-05Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
28,237
0.0659%
$19.57$552,478-7.55%
2024-01-04Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
40,732
0.0963%
$20.31$827,202-9.23%
2023-12-18Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
4,702
0.0105%
$18.13$85,243+2.03%
2023-12-15Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
28,632
0.0661%
$17.27$494,432+8.76%
2023-02-22Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
16,449
0.0502%
$20.22$332,665-13.63%
2023-02-21Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
17,997
0.0572%
$20.96$377,209-13.24%
2023-01-20Sale4D Molecular Therapeutics, Inc.
FDMT
Chief Executive Officer
8,625
0.0262%
$20.19$174,127-13.81%
Total: 23
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.